Background The clinical course of COVID-19 patients ranges from asymptomatic infection,
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …

COVID-19 pathophysiology is currently not fully understood, reliable prognostic factors
remain elusive, and few specific therapeutic strategies have been proposed. In this scenario …

Background COVID-19 is a complex, multi-system disease with varying severity and
symptoms. Identifying changes in critically ill COVID-19 patients' proteomes enables a better …

COVID-19 complications still present a huge burden on healthcare systems and warrant
predictive risk models to triage patients and inform early intervention. Here, we profile 893 …

In managing patients with coronavirus disease 2019 (COVID‐19), early identification of
those at high risk and real‐time monitoring of disease progression to severe COVID‐19 is a …

Background Global healthcare systems continue to be challenged by the COVID-19
pandemic, and there is a need for clinical assays that can help optimise resource allocation …

Recent study showed that around 80% of coronavirus disease-19 (COVID-19) patients are
moderate cases who will recover with or without conventional treatment, while the remaining …

Background COVID-19 has caused millions of deaths globally, yet the cellular mechanisms
underlying the various effects of the disease remain poorly understood. Recently, a new …

COVID-19 infections have imposed immense pressure on the healthcare system of most
countries. While the initial studies have identified better therapeutic and diagnostic …

The COVID-19 pandemic caused by SARS-CoV-2 challenges the understanding of factors
affecting disease progression and severity. The identification of prognostic biomarkers and …